Published in Osteoporos Int on January 01, 1999
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ (2008) 3.56
The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab (2011) 1.88
Mortality after vertebral fracture in Korea: analysis of the National Claim Registry. Osteoporos Int (2011) 1.51
Geographic trends in incidence of hip fractures: a comprehensive literature review. Osteoporos Int (2011) 1.44
Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int (2006) 1.44
Skeletal consequences of thiazolidinedione therapy. Osteoporos Int (2007) 1.42
Clinical and demographic factors associated with fractures among older Americans. Osteoporos Int (2010) 1.42
The burden of hospitalised fractures in Sweden. Osteoporos Int (2004) 1.41
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int (2006) 1.36
Fracture rates lower in rural than urban communities: the Geelong Osteoporosis Study. J Epidemiol Community Health (2002) 1.34
The human cost of fracture. Osteoporos Int (2005) 1.33
Epidemiology of distal forearm fractures in Oslo, Norway. Osteoporos Int (2008) 1.32
Incidence rates and life-time risk of hip fractures in Mexicans over 50 years of age: a population-based study. Osteoporos Int (2005) 1.23
Time trends of age-adjusted incidence rates of first hip fractures: a register-based study among older people in Viborg County, Denmark, 1987-1997. Osteoporos Int (2006) 1.19
Epidemiology of hip fractures in 2002 in Rabat, Morocco. Osteoporos Int (2004) 1.16
Femoral neck geometry and hip fracture risk: the Geelong osteoporosis study. Osteoporos Int (2005) 1.15
Epidemiology and seasonal variation of distal radius fractures in Oulu, Finland. Osteoporos Int (2010) 1.14
Epidemiology of hip fracture in Iran: results from the Iranian Multicenter Study on Accidental Injuries. Osteoporos Int (2006) 1.11
Epidemiology of hip and wrist fractures in Cameroon, Africa. Osteoporos Int (2003) 1.11
Incidence of hip fractures in Jeju Island, South Korea: a prospective study (2002-2006). Clin Orthop Surg (2010) 1.09
A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures. Osteoporos Int (2006) 1.07
Rate and circumstances of clinical vertebral fractures in older men. Osteoporos Int (2007) 1.07
Trials and tribulations of recruiting 2,000 older women onto a clinical trial investigating falls and fractures: Vital D study. BMC Med Res Methodol (2009) 1.03
Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older. Bone (2008) 1.00
What accounts for rib fractures in older adults? J Osteoporos (2011) 1.00
Bone mineral density predicts osteoporotic fractures in elderly men: the MINOS study. Osteoporos Int (2005) 1.00
Fracture risk in patients with prostate cancer on androgen deprivation therapy. Osteoporos Int (2005) 0.98
Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS). Osteoporos Int (2015) 0.96
Hip fractures in a city in Northern Norway over 15 years: time trends, seasonal variation and mortality : the Harstad Injury Prevention Study. Osteoporos Int (2011) 0.95
The gender- and age-specific 10-year and lifetime absolute fracture risk in Tromsø, Norway. Eur J Epidemiol (2009) 0.95
Prediction of incident osteoporotic fractures in elderly women using the free estradiol index. Osteoporos Int (2004) 0.90
Validation of a case definition for osteoporosis disease surveillance. Osteoporos Int (2010) 0.88
Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivation. PLoS One (2012) 0.87
Trend in hip fracture incidence and mortality in Korea: a prospective cohort study from 2002 to 2011. J Korean Med Sci (2015) 0.87
Depression following fracture in women: a study of age-matched cohorts. BMJ Open (2014) 0.85
A biomechanical approach to distal radius fractures for the emergency radiologist. Emerg Radiol (2015) 0.84
Fracture risk among older men: osteopenia and osteoporosis defined using cut-points derived from female versus male reference data. Osteoporos Int (2013) 0.84
Barriers to effective management of osteoporosis in moderate and minimal trauma fractures: a prospective study. Osteoporos Int (2004) 0.82
Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women. Osteoporos Int (2011) 0.82
Osteoporosis onset differences between rural and metropolitan populations: correlation to fracture type, severity, and treatment efficacy. J Bone Miner Metab (2011) 0.82
An Asian perspective on the management of distal radius fractures. Hand Clin (2012) 0.82
Methodological reflections on using pilot data from fracture patients to develop a qualitative study. BMC Res Notes (2011) 0.80
Polyalanine repeat polymorphism in RUNX2 is associated with site-specific fracture in post-menopausal females. PLoS One (2013) 0.80
Fracture incidence in a large cohort of men age 30 years and older with osteoporosis. Osteoporos Int (2015) 0.80
Rheumatoid arthritis and incident fracture in women: a case-control study. BMC Musculoskelet Disord (2014) 0.78
Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int (2017) 0.78
Reporting of lifetime fractures: methodological considerations and results from the Thai Cohort Study. BMJ Open (2012) 0.77
Updated classification system for proximal humeral fractures. Clin Med Res (2009) 0.77
Evidence for the treatment of osteoporosis with vitamin D in residential care and in the community dwelling elderly. Biomed Res Int (2013) 0.77
Non-hip and non-vertebral fractures: the neglected fracture sites. Osteoporos Int (2015) 0.76
The Shoulder Function Index (SFInX): a clinician-observed outcome measure for people with a proximal humeral fracture. BMC Musculoskelet Disord (2015) 0.76
Hormone therapy and risk of non-vertebral fracture: Geelong osteoporosis study. Osteoporos Int (2004) 0.76
Predictors of fracture from falls reported in hospital and residential care facilities: a cross-sectional study. BMJ Open (2013) 0.76
The Effect of Age on Fracture Risk: A Population-Based Cohort Study. J Aging Res (2016) 0.75
The Shoulder Function Index (SFInX): evaluation of its measurement properties in people recovering from a proximal humeral fracture. BMC Musculoskelet Disord (2016) 0.75
Osteoporosis in men: findings from the Osteoporotic Fractures in Men Study (MrOS). Ther Adv Musculoskelet Dis (2016) 0.75
High prevalence of vitamin D deficiency in 2-17 year olds presenting with acute fractures in southern Australia. Bone Rep (2016) 0.75
Minimal-trauma fracture in women with breast cancer surviving for at least 5 years from diagnosis. Osteoporos Int (2014) 0.75
Diversity in fall characteristics hampers effective prevention: the precipitants, the environment, the fall and the injury. Osteoporos Int (2017) 0.75
Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study. Rheumatol Int (2016) 0.75
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev (1999) 7.69
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Therapeutic approaches to bone diseases. Science (2000) 5.60
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med (2000) 5.02
Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A (1990) 4.40
Osteoblastic cells are involved in osteoclast formation. Endocrinology (1988) 4.37
Modulation of osteoclast differentiation. Endocr Rev (1992) 4.27
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int (1981) 3.77
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67
Exercise during growth and bone mineral density and fractures in old age. Lancet (2000) 3.06
A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis (1999) 2.93
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology (1989) 2.83
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA (1997) 2.46
The bone density of female twins discordant for tobacco use. N Engl J Med (1994) 2.44
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone (2002) 2.40
The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms. N Engl J Med (1984) 2.33
Malignant glaucoma after laser iridotomy. Ophthalmology (1992) 2.28
Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun (1999) 2.28
Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res (1991) 2.26
Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature (2000) 2.13
Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology (1999) 2.11
Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev (2006) 2.08
Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab (2001) 2.08
The hypercalcemia of malignancy: pathogenesis and management. Metabolism (1982) 2.01
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med (1996) 2.00
Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00
Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology (2001) 1.98
An unusual case of Marine-Lenhart syndrome. Thyroid (2003) 1.97
The effect of mechanical loading on the size and shape of bone in pre-, peri-, and postpubertal girls: a study in tennis players. J Bone Miner Res (2002) 1.95
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol (2002) 1.93
Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. J Bone Miner Res (1998) 1.88
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy. Br J Haematol (1996) 1.79
Exercise before puberty may confer residual benefits in bone density in adulthood: studies in active prepubertal and retired female gymnasts. J Bone Miner Res (1998) 1.77
Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology (1998) 1.75
The association between socioeconomic status and osteoporotic fracture in population-based adults: a systematic review. Osteoporos Int (2008) 1.75
A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology (1998) 1.75
Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest (1986) 1.73
Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem (2005) 1.71
Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone (1999) 1.66
The general practice care of people with intellectual disability: barriers and solutions. J Intellect Disabil Res (1997) 1.66
Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology (2001) 1.66
The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res (1998) 1.65
Health burden of hip and other fractures in Australia beyond 2000. Projections based on the Geelong Osteoporosis Study. Med J Aust (1999) 1.62
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology (2000) 1.61
Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res (1990) 1.61
Body fat distribution and non-insulin-dependent diabetes: comparison of a fiber-rich, high-carbohydrate, low-fat (23%) diet and a 35% fat diet high in monounsaturated fat. Am J Clin Nutr (1996) 1.60
Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med (1995) 1.60
The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica. Br J Rheumatol (1998) 1.59
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum (2001) 1.58
Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest (1993) 1.58
Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res (1990) 1.54
Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy. Science (1983) 1.52
The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int (2006) 1.52
IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol (2001) 1.52
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest (1982) 1.48
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res (2001) 1.47
Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis? J Bone Joint Surg Br (1981) 1.46
Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia. Lancet (1993) 1.45
The biomechanical basis of vertebral body fragility in men and women. J Bone Miner Res (2001) 1.45
Oral contraceptives and bone mineral density: A population-based study. Am J Obstet Gynecol (2000) 1.42
Short stature and delayed puberty in gymnasts: influence of selection bias on leg length and the duration of training on trunk length. J Pediatr (2000) 1.41
Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int (2000) 1.41
Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res (1983) 1.38
Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem Biophys Res Commun (1985) 1.38
Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum (2000) 1.37
Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther (1999) 1.35
Fracture rates lower in rural than urban communities: the Geelong Osteoporosis Study. J Epidemiol Community Health (2002) 1.34
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Structure of the 5' flanking region of the gene encoding human parathyroid-hormone-related protein (PTHrP). Gene (1989) 1.31